Reflections after the ecancer Tata Medical Center, Kolkata Psycho-oncology congress 2024
Dr Milena Cavic speaks to ecancer about the IASLC Early Detection and Screening Committee announcement in an effort to outline the current obstacles and perspectives of lung cancer screening in low- and middle-income countries and to propose guidance, recommendations, and future research strategies.
The Diagnostics Working Group of the IASLC Early Detection and Screening Committee has led to observations that for a systematic evaluation of the status of lung cancer screening in low-to middle-income countries, a comprehensive comparison of lung cancer incidence and mortality by stage at diagnosis would need to be conducted between low-to middle-income and high-income countries.
Click here for the results of the study with Professor Rudolf Huber, the co-author of this study.
My name is Milena Cavic, I come from the Institute for Oncology and Radiology of Serbia in Belgrade and I’m very happy to be here with you today to present the results of the Diagnostics Working Group of the IASLC Early Detection and Screening Committee. We’ve been performing some important work concerning implementation of screening programmes in low and middle income countries and we would like to get your help to get the widest outreach as possible.
The project was centred, actually, on covering the current state of the art in implementation of early detection and screening programmes worldwide. We focussed on researching data that is present in literature and also we performed very extensive research in our own countries because we have some members from low and middle income countries in the Diagnostics Working Group. The idea was to present all the obstacles that we could find and that we could reach consensus on, discuss them and initiate broader research on the topic, providing evidence-based guidelines on what the perspectives on the topic would be.
Reflections after the ecancer Tata Medical Center, Kolkata Psycho-oncology congress 2024
Synthetic biology and precision medicine in blood and gynaecological cancers
Introducing oncology to undergraduate medical and allied health sciences students
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for September 8-14, 2023
OncoAlert Round Up for August 4th - 10th, 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Cancer Care in Older Adults and Special Population